产品名称 | NebuSelect™ Recombinant Human CTLA-4/CD152, hFc-tag |
---|---|
目录号 | NBL-242760 |
别名 | CTLA-4/CD152; CTLA4; CD152; ICOS; CELIAC3; GRD4; GSE; ALPS5; IDDM12 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P16410-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242760-100ug | 100ug | Inquire | Inquire | |
NBL-242760-1mg | 1mg | Inquire | Inquire | |
NBL-242760-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CTLA-4/CD152, hFc-tag
Catalog#:
NBL-242760
Description:
NebuSelect™ Recombinant Human CTLA-4/CD152, hFc-tag(Cat#NBL-242760) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Lys36-Asp161.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 40.1 kDa. Due to glycosylation, the protein migrates to 50-55 kDa based on Bis-Tris PAGE result.
Target Name:
CTLA-4/CD152; CTLA4; CD152; ICOS; CELIAC3; GRD4; GSE; ALPS5; IDDM12
Target Information:
CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), also known as CD152, is a protein receptor that, functioning as an immune checkpoint, downregulates immune responses.CTLA4 is constitutively expressed in regulatory T cells but only upregulated in conventional T cells after activation – a phenomenon which is particularly notable in cancers. It acts as an "off" switch when bound to CD80 or CD86 on the surface of antigen-presenting cells.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.